Skip to main content

Table 2 Laboratory and echocardiographic data

From: Coronary microvascular function is independently associated with left ventricular filling pressure in patients with type 2 diabetes mellitus

Variables Patients n = 67 Controls n = 14 p
Laboratory data
 FBS (mg/dl) 130.9 ± 40.1 97.0 ± 6.7 <0.0001
 HbA1c (%) 7.8 ± 1.5 5.2 ± 0.2 <0.0001
 IRI (µU/l) 8.8 ± 8.3  
 HOMA-R 2.9 ± 3.2  
 TG (mg/dl) 112.7 ± 50.2 120.0 ± 48.1 0.64
 HDL-C (mg/dl) 46.1 ± 14.0 48.3 ± 7.7 0.43
 LDL-C (mg/dl) 107.5 ± 27.2 114.0 ± 31.9 0.50
 Creatinine (mg/dl) 0.79 ± 0.19 0.74 ± 0.14 0.31
 eGFR ml/min./1.73 m2 78.1 ± 19.3 79.9 ± 13.3 0.69
Echocardiographic data
 Left atrial diameter (mm) 36.2 ± 4.4 33.5 ± 4.3 0.044
 RWT 0.43 ± 0.07 0.43 ± 0.06 0.72
 LV mass index (g/m2) 84.7 ± 21.4 77.1 ± 14.7 0.13
 LVEDV index (ml/m2) 55.8 ± 11.4 54.3 ± 8.9 0.61
 LVESV index (ml/m2) 18.2 ± 5.0 18.5 ± 3.3 0.81
 LVEF (%) 67.2 ± 5.1 65.6 ± 5.1 0.34
 E/A 0.9 ± 0.3 0.9 ± 0.2 0.42
 DT (msec) 194.8 ± 45.1 182.9 ± 42.0 0.37
 Septal e′ (cm/sec) 7.0 ± 2.2 7.9 ± 1.7 0.11
 E/e′ 9.3 ± 2.7 7.6 ± 1.1 0.0004
 MDV baseline (cm/sec) 15.3 ± 3.5 15.2 ± 3.9 0.89
 MDV hyperemia (cm/sec) 50.6 ± 12.6 56.8 ± 11.6 0.088
 CFR 3.3 ± 0.8 3.8 ± 0.7 0.036
  1. Data are presented as mean ± SD.
  2. FBS fasting blood sugar, HbA1c glycated hemoglobin, IRI immunoreactive insulin, HOMA-R homeostasis model assessment ratio, T-Cho total-cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, eGFR estimated glomerular filtration rate, RWT relative wall thickness, LVEDV/ESV left ventricular end-diastolic volume/end-systolic volume, LVEF left ventricular ejection fraction, DT deceleration time of mitral E wave, MDV mean diastolic coronary flow velocity, CFR coronary flow reserve.